Xultophy Injection (Insulin Degludec and Liraglutide): Uses, Dosage, Side Effects, Interactions, Warning
These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6. XULTOPHY® 100/3.6 (insulin degludec and liraglutide injection), for subcutaneous
Novo Nordisk Receives FDA Approval for Xultophy® 100/3.6 (insulin degludec and liraglutide injection)
These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6. XULTOPHY® 100/3.6 (insulin degludec and liraglutide injection), for subcutaneous
Xultophy® 100/3.6 Patient Assistance Program (PAP) | NovoCare®